can you combine sglt2 and glp 1 Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM) | Cardiovascular Diabetology Effect of combination treatment with

4.7 Pregnancy-related effects Although type 2 diabetes and obesity have been effectively treated with GLP-1 receptor agonists, their role in pregnancy and breastfeeding has been a controversial debate due to potential risks to the mothers health and fetal outcomes (87)

Multidisciplinary collaboration and close maternalfetal monitoring remain essential components of care

Patients should be advised about the urine discoloration (to avoid alarm) and counseled to report any persistent side effects

The below chemical properties represent the Retatrutide base (2381089-83-2), whereas most commonly, the acetate is the fully prepared form of Retatrutide (LY3437943) which is the product Modern Peptides offers